KURA logo

Kura Oncology, Inc. (KURA)

Profile

Full Name

Kura Oncology, Inc.

Ticker

NASDAQ: KURA

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

September 16, 2015

Indexes

Not included

Website

https://kuraoncology.com

Employees

192

Key Details

Price

$8.19(-7.20%)

Market cap

$710.87M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$53.88M(+100.00% YoY)

Annual EPS

-$2.02(+2.88% YoY)

PE ratio

-

Next earnings date

Nov 6, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $8.19
    KURA price is $8.19

    30-Day Relative Volume

    0.83
    KURA 30-day relative volume is 0.83

    Price Performance

    Price Most recent change

    -7.2%
    KURA price was down -7.2% on Sep 12, 2025

    Price YTD change

    -5.97%
    KURA price is down -5.97% since January 1st

    Price 1-year change

    -58.82%
    KURA price is down -58.82% year-on-year

    Price 3-year change

    -45.4%
    KURA price is down -45.4% over the past 3 years

    Price Range

    Price All-time high

    $43.00
    KURA price is currently -80.95% below its historical high of $43.00

    Price 3-year low

    $5.41
    KURA price is currently +51.39% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $710.87M
    KURA market capitalization is $710.87 million

    Market cap 3-year change

    -29.15%
    KURA market capitalization is down -29.15% over the past 3 years

    Market cap All-time high

    $2.75B
    KURA market capitalization is currently -74.13% below its historical high of $2.75 billion

    Market cap sector rank

    68.2%
    KURA market capitalization is higher than 68.2% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +13.26%
    KURA shares outstanding is up +13.26% year-on-year

    Shares Outstanding 3-Year Change

    +29.76%
    KURA shares outstanding is up +29.76% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.89
    KURA beta is 0.89

    200-day SMA

    $7.31
    KURA price is currently +12.07% above its 200-day simple moving average

    50-day SMA

    $6.87
    KURA price is currently +19.21% above its 50-day simple moving average

    RSI

    58.76
    KURA 14-day relative strength index is 58.76

    Volume

    0.83
    KURA 30-day relative volume is 0.83

    ATR

    $0.51
    KURA average true range is $0.51

    10-day Historical Volatility

    70.66%
    KURA 10-day historical volatility is 70.66%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $53.88M
    KURA annual revenue is $53.88 million

    Revenue Analysts estimate

    $148.79M
    KURA annual revenue is currently -63.78% lower than the consensus analysts' forecast

    Revenue 1-year change

    +100%
    KURA annual revenue is up +100% year-on-year

    Revenue Sector rank

    61.98%
    KURA annual revenue is higher than 61.98% of companies in Healthcare sector

    EPS

    EPS

    -$2.02
    KURA annual earnings per share is -$2.02

    EPS Analysts estimate

    -$2.23
    KURA annual earnings per share is currently -9.52% lower than the consensus analysts' forecast

    EPS 1-year change

    +2.88%
    KURA annual earnings per share is up +2.88% year-on-year

    EPS Sector rank

    36.89%
    KURA annual earnings per share is higher than 36.89% of companies in Healthcare sector

    Profit

    Gross profit

    $53.03M
    KURA annual gross profit is $53.03 million

    Gross margin

    98.43%
    KURA annual gross profit margin is 98.43%

    Operating profit

    -$193.19M
    KURA annual operating income is -$193.19 million

    Operating margin

    -358.55%
    KURA annual operating profit margin is -358.55%

    Net income

    -$173.98M
    KURA annual net profit is -$173.98 million

    Net margin

    -322.89%
    KURA annual net profit margin is -322.89%

    Expenses

    Total expenses

    $227.87M
    KURA annual total expenses is $227.87 million

    Operating expenses

    $246.23M
    KURA annual total operating expenses is $246.23 million

    Cost of goods sold

    $848.00K
    KURA annual cost of goods sold is $848.00 thousand

    Selling, general & administrative expenses

    $0.00
    KURA annual SGA is $0.00

    Depreciation and amortization

    $848.00K
    KURA annual depreciation & amortization is $848.00 thousand

    Interest expense

    $0.00
    KURA annual interest expense is $0.00

    Income tax

    $2.02M
    KURA annual income tax is $2.02 million

    EBIT & EBITDA

    EBIT

    -$193.19M
    KURA annual earnings before interest & taxes is -$193.19 million

    EBITDA

    -$192.35M
    KURA annual EBITDA is -$192.35 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $1.04B
    KURA annual total assets is $1.04 billion

    Non current assets

    $15.33M
    KURA annual long term assets is $15.33 million

    Current assets

    $744.83M
    KURA annual total current assets is $744.83 million

    Cash and cash equivalents

    $224.46M
    KURA annual cash & cash equivalents is $224.46 million

    Accounts receivable

    -
    KURA annual accounts receivable value is unknown

    Inventory

    $0.00
    KURA annual inventory is $0.00

    Liabilities

    Total liabilities

    $627.03M
    KURA annual total liabilities is $627.03 million

    Long term liabilities

    $267.81M
    KURA annual total long term liabilities is $267.81 million

    Current liabilities

    $78.71M
    KURA annual total current liabilities is $78.71 million

    Accounts payable

    $1.47M
    KURA annual accounts payable is $1.47 million

    Debt

    Total debt

    $16.59M
    KURA annual total debt is $16.59 million

    Total debt 1-year change

    -3.52%
    KURA annual total debt is down -3.52% year-on-year

    Long term debt

    $12.11M
    KURA annual long term debt is $12.11 million

    Short term debt

    $4.49M
    KURA annual short term debt is $4.49 million

    Equity & Capital

    Shareholders equity

    $413.64M
    KURA annual stockholders equity is $413.64 million

    Book value

    $413.64M
    KURA annual book value is $413.64 million

    Retained earnings

    -$895.42M
    KURA annual retained earnings is -$895.42 million

    Working capital

    $666.12M
    KURA annual working capital is $666.12 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    $134.32M
    KURA annual cash flow from operations is $134.32 million

    Cash from operations 1-year change

    +207.61%
    KURA annual cash flow from operations is up +207.61% year-on-year

    Cash from investing

    -$101.59M
    KURA annual cash flow from investing activities is -$101.59 million

    Cash from investing 1-year change

    -753.02%
    KURA annual cash flow from investing activities is down -753.02% year-on-year

    Cash from financing

    $154.42M
    KURA annual cash flow from financing activities is $154.42 million

    Cash from financing 1-year change

    +62.92%
    KURA annual cash flow from financing activities is up +62.92% year-on-year

    CAPEX

    CAPEX

    $472.00K
    KURA annual capital expenditures is $472.00 thousand

    CAPEX 1-year change

    +180.95%
    KURA annual capital expenditures is up +180.95% year-on-year

    Free Cash Flow

    Free cash flow

    $133.84M
    KURA annual free cash flow is $133.84 million

    Free cash flow 1-year change

    +207.08%
    KURA annual free cash flow is up +207.08% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    98.43%
    KURA annual gross profit margin is 98.43%

    Operating margin

    -358.55%
    KURA annual operating profit margin is -358.55%

    Net margin

    -322.89%
    KURA annual net profit margin is -322.89%

    ROA & ROE

    ROA

    -23.36%
    KURA annual return on assets is -23.36%

    ROE

    -42.91%
    KURA annual return on equity is -42.91%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    KURA price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    KURA price to earnings ratio is unknown

    PB Ratio

    PB ratio

    2.33
    KURA price to book ratio is 2.33

    PB ratio Sector rank

    57.74%
    KURA price to book ratio is higher than 57.74% of companies in Healthcare sector

    PS Ratio

    PS ratio

    8.54
    KURA price to sales ratio is 8.54

    PS ratio Sector rank

    70.3%
    KURA price to sales ratio is higher than 70.3% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $99.61M
    KURA enterprise value is $99.61 million

    Enterprise value Sector rank

    46.45%
    KURA enterprise value is higher than 46.45% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -0.52
    KURA EV/EBITDA is -0.52

    EV/EBITDA Sector rank

    53.85%
    KURA EV/EBITDA is higher than 53.85% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    9.46
    KURA annual current ratio is 9.46

    Quick ratio

    9.46
    KURA annual quick ratio is 9.46

    Leverage

    Debt to equity

    0.04
    KURA annual debt to equity ratio is 0.04

    Interest coverage ratio

    -
    KURA annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    KURA piotroski f-score value is unknown

    Altman Z-Score

    -0.32
    KURA altman z-score is -0.32

    Analyst ratings

    Recent major analysts updates

    Sep 4, 25 Guggenheim
    Neutral
    Aug 11, 25 JMP Securities
    Market Outperform
    Jun 26, 25 Cantor Fitzgerald
    Overweight
    Jun 20, 25 Wedbush
    Outperform
    Jun 4, 25 JMP Securities
    Market Outperform
    May 19, 25 Mizuho
    Outperform
    May 2, 25 Barclays
    Overweight
    Apr 29, 25 JMP Securities
    Market Outperform
    Apr 28, 25 HC Wainwright & Co.
    Buy
    Mar 6, 25 UBS
    Buy

    Institutional Ownership

    Screeners with KURA included

    Growing Shares Outstanding
    US stocks
    Best performing stocks last month
    Most recommended stocks
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    • What is the ticker symbol for Kura Oncology, Inc.?
    • Does Kura Oncology, Inc. pay dividends?
    • What sector is Kura Oncology, Inc. in?
    • What industry is Kura Oncology, Inc. in?
    • What country is Kura Oncology, Inc. based in?
    • When did Kura Oncology, Inc. go public?
    • Is Kura Oncology, Inc. in the S&P 500?
    • Is Kura Oncology, Inc. in the NASDAQ 100?
    • Is Kura Oncology, Inc. in the Dow Jones?
    • When was Kura Oncology, Inc.'s last earnings report?
    • When does Kura Oncology, Inc. report earnings?

    What is the ticker symbol for Kura Oncology, Inc.?

    The ticker symbol for Kura Oncology, Inc. is NASDAQ:KURA

    Does Kura Oncology, Inc. pay dividends?

    No, Kura Oncology, Inc. does not pay dividends

    What sector is Kura Oncology, Inc. in?

    Kura Oncology, Inc. is in the Healthcare sector

    What industry is Kura Oncology, Inc. in?

    Kura Oncology, Inc. is in the Biotechnology industry

    What country is Kura Oncology, Inc. based in?

    Kura Oncology, Inc. is headquartered in United States

    When did Kura Oncology, Inc. go public?

    Kura Oncology, Inc.'s initial public offering (IPO) was on September 16, 2015

    Is Kura Oncology, Inc. in the S&P 500?

    No, Kura Oncology, Inc. is not included in the S&P 500 index

    Is Kura Oncology, Inc. in the NASDAQ 100?

    No, Kura Oncology, Inc. is not included in the NASDAQ 100 index

    Is Kura Oncology, Inc. in the Dow Jones?

    No, Kura Oncology, Inc. is not included in the Dow Jones index

    When was Kura Oncology, Inc.'s last earnings report?

    Kura Oncology, Inc.'s most recent earnings report was on August 7, 2025

    When does Kura Oncology, Inc. report earnings?

    The next expected earnings date for Kura Oncology, Inc. is November 6, 2025
    On this page